Guangdong Province Traditional Chinese Medical Hospitsal

Guangzhou, Guangdong 510655

0 studies enrolling now · 1 studies all time

What they study most

Esophageal Squamous Cell Carcinoma (ESCC)

Studies at this site

• A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma — Completed